Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

7,296 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Advances in immunopathogenesis of adult immune thrombocytopenia.
Liu X, Hou Y, Peng J. Liu X, et al. Among authors: hou y. Front Med. 2013 Dec;7(4):418-24. doi: 10.1007/s11684-013-0297-8. Epub 2013 Nov 21. Front Med. 2013. PMID: 24264165 Review.
Contributions of TRAIL-mediated megakaryocyte apoptosis to impaired megakaryocyte and platelet production in immune thrombocytopenia.
Yang L, Wang L, Zhao CH, Zhu XJ, Hou Y, Jun P, Hou M. Yang L, et al. Among authors: hou y, hou m. Blood. 2010 Nov 18;116(20):4307-16. doi: 10.1182/blood-2010-02-267435. Epub 2010 Jul 29. Blood. 2010. PMID: 20671119
Th22 cells as well as Th17 cells expand differentially in patients with early-stage and late-stage myelodysplastic syndrome.
Shao LL, Zhang L, Hou Y, Yu S, Liu XG, Huang XY, Sun YX, Tian T, He N, Ma DX, Peng J, Hou M. Shao LL, et al. Among authors: hou y, hou m. PLoS One. 2012;7(12):e51339. doi: 10.1371/journal.pone.0051339. Epub 2012 Dec 7. PLoS One. 2012. PMID: 23236476 Free PMC article.
Therapeutic effects of thalidomide in hematologic disorders: a review.
Xu M, Hou Y, Sheng L, Peng J. Xu M, et al. Among authors: hou y. Front Med. 2013 Sep;7(3):290-300. doi: 10.1007/s11684-013-0277-z. Epub 2013 Jul 15. Front Med. 2013. PMID: 23856973 Review.
Thalidomide corrects impaired mesenchymal stem cell function in inducing tolerogenic DCs in patients with immune thrombocytopenia.
Ma J, Ning YN, Xu M, Hou Y, Wang N, Hou XY, Yu YY, Li H, He WD, Shao LL, Zhou H, Min YN, Liu XG, Shi Y, Qin P, Guo CS, Hou M, Peng J. Ma J, et al. Among authors: hou y, hou xy, hou m. Blood. 2013 Sep 19;122(12):2074-82. doi: 10.1182/blood-2013-03-491555. Epub 2013 Aug 7. Blood. 2013. PMID: 23926306
Interleukin 27 inhibits cytotoxic T-lymphocyte-mediated platelet destruction in primary immune thrombocytopenia.
Zhou H, Qiu JH, Wang T, Yu YY, Liu XN, Li X, Wang YW, Hou Y, Li LZ, Liu XG, Hou M, Peng J. Zhou H, et al. Among authors: hou y, hou m. Blood. 2014 Nov 20;124(22):3316-9. doi: 10.1182/blood-2014-06-580084. Epub 2014 Oct 8. Blood. 2014. PMID: 25298039 Free PMC article.
Imbalance between CD205 and CD80/CD86 in dendritic cells in patients with immune thrombocytopenia.
Zhang XL, Ma J, Xu M, Meng F, Qu M, Sun J, Qin P, Wang L, Hou Y, Song Q, Peng J, Hou M. Zhang XL, et al. Among authors: hou y, hou m. Thromb Res. 2015 Feb;135(2):352-61. doi: 10.1016/j.thromres.2014.11.042. Epub 2014 Dec 19. Thromb Res. 2015. PMID: 25554498
Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia.
Zhou H, Hou Y, Liu X, Qiu J, Feng Q, Wang Y, Zhang X, Min Y, Shao L, Liu X, Li G, Li L, Yang L, Xu S, Ni H, Peng J, Hou M. Zhou H, et al. Among authors: hou y, hou m. Thromb Haemost. 2015 May;113(5):1021-34. doi: 10.1160/TH14-04-0342. Epub 2015 Jan 8. Thromb Haemost. 2015. PMID: 25566808
Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia.
Hu Y, Wang X, Yu S, Hou Y, Ma D, Hou M. Hu Y, et al. Among authors: hou y, hou m. Expert Opin Ther Targets. 2015 Jun;19(6):723-32. doi: 10.1517/14728222.2015.1016499. Expert Opin Ther Targets. 2015. PMID: 25976230
High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia.
Hou Y, Feng Q, Xu M, Li GS, Liu XN, Sheng Z, Zhou H, Ma J, Wei Y, Sun YX, Yu YY, Qiu JH, Shao LL, Liu XG, Hou M, Peng J. Hou Y, et al. Among authors: hou m. Blood. 2016 Mar 24;127(12):1587-97. doi: 10.1182/blood-2015-10-674531. Epub 2016 Jan 7. Blood. 2016. PMID: 26744458
7,296 results
Jump to page
Feedback